Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Options Exercise | $1.38M | +33.6K | +26.5% | $41.04 | 160K | Oct 29, 2021 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$6.04M | -33.6K | -20.95% | $180.00 | 127K | Oct 29, 2021 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -33.6K | -100% | $0.00* | 0 | Oct 29, 2021 | Common Stock | 33.6K | $41.04 | Direct | F4 |
Id | Content |
---|---|
F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 11, 2020. |
F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $180.00 to $180.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F4 | Options shall vest at a rate of 25% on August 19, 2014 and monthly thereafter until all the options are fully vested on August 19, 2017. |